Immunology
Catching up with the Alliance for Regenerative Medicine at Cell & Gene Meeting on the Mesa
CARLSBAD, CA - What's going on at this week's Cell & Gene Meeting on the Mesa? ScienceBoard.net spoke with Stephen Majors, director of public affairs at the Alliance for Regenerative Medicine, who shared what's being discussed at this year's meeting. Read More
What's next for cellular immunotherapies?
CARLSBAD, CA - What's the next step in the development of cellular immunotherapies, particularly for liquid and solid tumors? At this week's Cell & Gene Meeting on the Mesa, Dr. Kanya Rajangam, PhD, of Nkarta Therapeutics explained the latest approaches. Read More
Tecartus becomes 1st CAR T-cell therapy to receive FDA approval for adults with ALL
Tecartus (brexucabtagene autoleucel), a CAR T-cell therapy, has gained approval from the U.S. Food and Drug Administration (FDA) for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in adult patients. Read More
Cytek launches new immunoprofiling assay
Cytek Biosciences has launched a 25-color immunoprofiling assay optimized for its flagship Aurora cell analysis systems. Read More
Scientists tease out role of epithelial cells in lung immunity
A research group has shown how different lung cell roles guide the immune system, according to a study published online on October 5 in Nature Communications. The findings have larger implications in understanding, preventing, and treating multiple lung pathologies, such as those seen in COVID-19. Read More
How one company aims to make bedside cell therapies a reality
SQZ Biotech is developing high-throughput technology that can manufacture novel cell therapy products in under 24 hours. Founder and CEO Armon Sharei, PhD, spoke with ScienceBoard.net recently at Biotech Week Boston 2021. Read More
Conferences
Science Briefs
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter